Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis. NLM AIDSLINE Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis.

Clin Exp Dermatol. 1997 Sep;22(5):216-9. Unique Identifier : AIDSLINE MED/98197605
Langtry JA; Rowland Payne CM; Staughton RC; Stewart JC; Horrobin DF; Department of Dermatology, Westminster Hospital, London, UK.


Abstract: A randomised, double-blind, placebo-controlled trial with lithium succinate ointment was conducted in patients with AIDS-associated facial seborrhoeic dermatitis. Twice daily applications of the ointment brought about a rapid (2.5 days) and highly significant P = 0.007) improvement in the severity of the condition. Lithium succinate ointment is well tolerated and can be a useful treatment for seborrhoeic dermatitis in this group of patients.
Keywords: *Acquired Immunodeficiency Syndrome/COMPLICATIONS *Dermatitis, Seborrheic/DRUG THERAPY *Dermatologic Agents/THERAPEUTIC USE *Facial Dermatoses/DRUG THERAPY *Lithium Compounds/THERAPEUTIC USE

KWDacquiredimmunodeficiencysyndrome/complicationsKWDdermatitis,seborrheic/drugtherapyKWDdermatologicagents/therapeuticuseKWDfacialdermatoses/drugtherapyKWDlithiumcompounds/therapeuticuse
980730
M9871329


Copyright © 1998 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .